NLB Resource - Clinical Trials (https://www.myeloma.org/myeloma-nurse-resources/nlb-resource-clinical-trials)
NLB Resource - Clinical Trials
Myeloma patients should be considered for clinical trials during all phases of treatment. The novel agents available for myeloma have all been developed through the clinical trials process, substantially increasing survival of myeloma patients over a short period of time.
Search the Myeloma Matrix 2.0 (https://www.myeloma.org/node/1168) to locate clinical trials for myeloma by geographic location and phase of treatment
(https://www.myeloma.org/resource-library/understanding-clinical-trials-myeloma)Related Content
The Advanced Practitioner's Guide to Multiple Myeloma
JADPRO Vol. 7 | Supplement 1 | March 2016
Sequencing of Treatment and Integration of Clinical Trials (https://www.advancedpractitioner.com/cme-supplements/volume-7,-supplement-1-(mar-2016)/sequencing-of-treatment-and-integration-of-clinical-trials.aspx)
The International Myeloma Foundation medical and editorial content team
Comprised of oncology-certified nurses, the Nurse Leadership Board has extensive knowledge of the multiple myeloma treatment and care landscape. These resources were developed by their team.
Last Medical Content Review: November 5, 2021